metalloprotease inhibitors (Rutgers University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namemetalloprotease inhibitors (Rutgers University)
Drug Alias Namemetalloprotease inhibitors (University of Medicine and Dentistry of New Jersey)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsChlamydia Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Medicine And Dentistry Of New Jersey
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Medicine And Dentistry Of New JerseyRutgers University
Active IndicationsN/A
Inactive IndicationsChlamydia Infections

Other Information

ATC CodeN/A
Related LinksN/A